Apotex Begins Roll Out Of Avastin Biosimilar In Canada
Product Of The Company’s Strategic Partnership With Mabxience
Following recent Health Canada approval, Apotex has launched partner mAbxience’s Bambevi (bevacizumab) biosimilar across Canada, adding to its portfolio of biosimilars that includes both filgrastim and pegfilgrastim.
